Trial Profile
A study to evaluate optimal blood concentration of total sunitinib in Japanese patients with metastatic renal cell carcinoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Apr 2016
Price :
$35
*
At a glance
- Drugs Sunitinib (Primary)
- Indications Renal cell carcinoma
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 01 Apr 2016 New trial record